Search results
Results from the WOW.Com Content Network
The BNF for Children developed from the British National Formulary (BNF), which prior to 2005 had provided information on the treatment of children, with the doses largely determined by calculations based on the body weight of the child. The guidance was provided by pharmacists and doctors whose expertise was in the care of adults.
The British National Formulary for Children (BNFC) [1] [19] [20] book, first published September 2005, [2] is published yearly, [2] and details the doses and uses of medicines in children from neonates to adolescents. [1]
A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. [1] Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication (a resource closer to what would be referred to as a pharmacopoeia ...
The following other wikis use this file: Usage on af.wikipedia.org Bibliothèque nationale de France; Usage on ar.wikipedia.org المكتبة الوطنية الفرنسية
Formula: C 12 H 20 N 4 O 7: Molar mass: 332.313 g·mol −1: 3D model ... In children with asthma there was no clear effect on the time to first alleviation of ...
Amino acid-based formula may be considered hypoallergenic since it does not contain peptides that may trigger an immune response. [ 3 ] Because infants and children have different nutritional needs, amino acid-based formulas are typically formulated either for infants 0–1 years of age or for children 1–10 years of age.
Artesunate is the first-line treatment for children or adults with severe malaria, [16] [17] [18] usually in combination with another antimalarial drug. There is moderate-quality evidence that treatment with artesunate plus mefloquine is superior to treatment with artesunate plus amodiaquine or artesunate plus sulfadoxine-pyrimethamine. [19]
Atomoxetine is approved for use in children, adolescents, and adults. [5] However, its efficacy has not been studied in children under six years old. [8] One of the primary differences with the standard stimulant treatments for ADHD is that it has little known abuse potential. [8]